LS Catalyst Startup Application

LS Catalyst North America Investor Connect

Application Deadline: Wednesday, May 6th, 2020

Life Sciences Queensland Limited (LSQ) invites top-tier early-stage companies in therapeutics, medical devices, diagnostics, and digital health from Queensland to apply for LS Catalyst North America Investor Connect. Successful applicants will have the opportunity to travel with Life Sciences Queensland to participate at Inventures 2020 3-5 June, Calgary, Redefining Early Stage Investments (RESI) 8 June, San Diego, and the BIO International Convention 8-11 June, San Diego.The five applicants who are deemed most suitable for early-stage investment will be selected and offered a place in the LSQ North America mission, an AUD$5000 travel allowance and may have the opportunity to present a poster or pitch to investors at RESI. These companies will also be required to participate in LSQ on-boarding training program prior to the mission's departure to ensure they are pitch ready.There is no fee to apply and applications will be reviewed by LSQ and Life Sciences Nation. Please familiarise yourself with the terms and conditions and complete this application form. Please note that a commercial-stage company (except digital health) would not be suitable.In addition to the application, you may submit any additional, non-confidential materials such as your pitch deck and executive summary to support@lsq.com.au for the team to review along with your application.Please click here to access the application form.